Some people who have mesothelioma don’t produce enough of a certain enzyme. The lack of this enzyme is thought to help mesothelioma grow and spread. Researchers in England and in the U.S. recently wrapped up a Phase 2 clinical trial of a drug designed to make up for this enzyme shortage. The results seem encouraging.
Monthly Archives: October 2016
Another molecular target for treating malignant pleural mesothelioma may have been found. So says a team of researchers from Hyogo College of Medicine in Nishinomiya, Japan. Nothing’s certain about this yet. But the researchers say that drugs aimed at interfering with a particular type of protein found in human cells could help improve mesothelioma survival.
The type of asbestos to which you were exposed doesn’t appear to have anything to do with how good or bad your mesothelioma prognosis is. The same goes for the form the asbestos was in when you encountered it. That’s also true with regard to where you came into contact with the toxic mineral –
Ending the scourge of mesothelioma could be done in one of two ways. First, find a cure. Second, stop people from becoming exposed to asbestos. Stopping asbestos exposure would mean no more mesothelioma, because exposure to asbestos is what causes it. Elected officials in the nation’s capital are taking steps to stop asbestos exposure from
Mesothelioma is difficult to beat back. There are many theories about why this is so. The newest of these ideas has to do with pleural effusions. Scientists in Australia think there’s something about these fluids that helps malignant pleural mesothelioma grow, spread and resist chemotherapy. The researchers are from the University of Western Australia, the
One way your doctor can tell if you have malignant pleural mesothelioma is by doing a thoracoscopy of your lung region. Many doctors like this procedure because it’s relatively simple and quick. Other doctors aren’t fans of it because they question how well they can trust what it reveals is going on inside you. Researchers
Mesothelioma survival averages eight to 12 months, many experts say. Others say it averages six to 18 months. Still others have different numbers entirely. No matter who’s right, one thing you can probably count on as a mesothelioma patient is pain for some, most or all of the time you have this cancer. The pain
A large number of people from coast to coast took part in the iWalk4MESO Virtual Race on Sept. 26, Mesothelioma Awareness Day. iWalk4MESO drew greater attention to mesothelioma and raised funds for medical research aimed at finding a cure for mesothelioma. Organizers from Weitz & Luxenberg P.C. reported that participation in the challenge exceeded expectations.
